A Randomised, Double-blind, Double-dummy, Parallel-group Multicentre Study to Assess Efficacy and Safety of Fluticasone Furoate/GW642444 Inhalation Powder and Fluticasone Propionate/Salmeterol Inhalation Powder in the Treatment of Persistent Asthma in Adults and Adolescents
收藏DataCite Commons2025-02-10 更新2026-05-07 收录
下载链接:
https://search.vivli.org/doiLanding/studies/00000939/isLanding
下载链接
链接失效反馈官方服务:
资源简介:
The purpose of the study is to compare the efficacy and safety of fluticasone furoate/vilanterol (GW642444) inhalation powder administered once daily with fluticasone propionate/salmeterol administered twice daily in adolescent and adult subjects 12 years of age and older with persistent bronchial asthma over a 24-week period.
提供机构:
Vivli
创建时间:
2018-10-27



